
Waters Announces New Mass Spectrometry Technology
Waters announces it will introduce its new technology at the 63rd Society of Mass Spectrometry conference.
On May 27, 2015, Waters announced that it will reveal new technology at the
Also to be introduced at the conference is the Oasis PRiME HLB and ACQUITY UPLC Glycoprotein BEH Amide 300Å 1.7-µm Column. Oasis, a solid- phase extraction product, provides samples for liquid chromatography and liquid chromatography-mass spectrometry analyses in an efficient manner. ACQUITY column is designed to help locate glycan molecules in the development of therapeutic proteins.
“Waters has been leading the way in innovative solutions for glycan analysis to help our biopharmaceutical customers solve the challenges they face with their traditional glycan workflows. The new ACQUITY UPLC Glycoprotein BEH Amide Column, joins a family of market leading disruptive technologies, including our Biopharmaceutical Platform Solution with UNIFI for characterization, and our most recent GlycoWorks™ RapiFluor-MS N-Glycan sample preparation kits,” said Mike Yelle, vice-president of Waters’ consumable business unit, in a press release.
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.